Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Ali

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Gene Therapy|November 15, 2024
Retraction Note: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsX Sun, B Pawlyk, X Xu, et al.
Gene Therapy|June 27, 2008
Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitisP Trittibach, S E Barker, C A Broderick, et al.
Gene Therapy|September 9, 2015
Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosaB S Pawlyk, O V Bulgakov, X Sun, et al.
Gene Therapy|October 7, 2006
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epitheliumG Le Meur, K Stieger, A J Smith, et al.
Nature Genetics|July 11, 2000
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapyR R Ali, G M Sarra, C Stephens, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
Gene Therapy|July 27, 2018
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 12, 2024
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|September 23, 2016
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 29, 2003
Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retinaJ W B Bainbridge, A Mistry, F C Schlichtenbrede, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Gene Therapy|November 15, 2024
Retraction Note: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsX Sun, B Pawlyk, X Xu, et al.
Gene Therapy|June 27, 2008
Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitisP Trittibach, S E Barker, C A Broderick, et al.
Gene Therapy|September 9, 2015
Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosaB S Pawlyk, O V Bulgakov, X Sun, et al.
Gene Therapy|October 7, 2006
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epitheliumG Le Meur, K Stieger, A J Smith, et al.
Nature Genetics|July 11, 2000
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapyR R Ali, G M Sarra, C Stephens, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
Gene Therapy|July 27, 2018
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 12, 2024
Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|September 23, 2016
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65A Georgiadis, Y Duran, J Ribeiro, et al.
Gene Therapy|July 29, 2003
Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retinaJ W B Bainbridge, A Mistry, F C Schlichtenbrede, et al.
Pageof 8